About Us » Site Map

GenScript ProBio Site Map


Biologics Discovery

Antibody Lead Generation

Hybridoma Generation for Therapeutic Antibody Discovery

ProSpeedTM Single B cell Antibody Discovery

Fully Human Antibody Discovery by Transgenic Mice

Human Fab Naïve Library

Solution for Novel Biologics Modalities

Bispecific Antibody DiscoveryNEW!

Innovative SMABody Bispecific Antibody Discovery

CAR Lead Discovery

Single Domain Antibody Discovery

ADC Discovery Service

Antibody Discovery Solution for Multi-pass Membrane Targets

Antibody Lead Optimization

Antibody Humanization

Antibody Affinity Maturation

Fc Engineering Service

Developability Assessment

Pharmacology & Discovery Reagent Service

In Vitro Pharmacology


GPCR-targeted Assay

Cytokine Neutralization Assay

ADC Bioassay Service

Immune Checkpoint Reporter Assay

Immune Checkpoint Primary Cell Assay

Pseudovirus Neutralization Assay Services for SARS-CoV-2

Engineered Cell Line based Bioassay Service

Bispecific Antibody Bioassay ServiceNEW!

In Vivo Pharmacology

In Vivo Efficacy

Pharmacokinetics Study

Toxicology Study

Biomarker testing and bioanalysis

Anti-idiotype Antibody and Immunoassay Development

PK and ADA Assay Development Services

Anti-idiotype antibody case study

Universal PK Tool Antibody Service for Antibody Drug

Affinity Measurement

Biologics CDMO

Fast Sample Preparation

Cell Line Development

ADCC Enhanced Cell Line Development

Host Cell Commercial License

GMP Cell Banking

IND-enabling CMC

Perfusion Process Development

CMC Case Study

Bioanalytical Development

ADCC & CDC Assays

Protein/Ab Characterization

SARS-CoV-2 Neutralizing Antibody In Vitro Bioassay Services

Bioassay Characterization NEW!

Antibody & Protein CMC Solutions for CGT

Process Characterization & Process Validation

200-500L Drug Substance Manufacturing

2000L Drug Substance Manufacturing

Aseptic Fill & Finish

ProBox™ Process Development Tool Box

UproCHO™ Medium System


Plasmid CDMO Services

LentiHelperTM Plasmid Products

AAssistVTM Plasmid Products

Plasmid CMC for IND

Plasmid Manufacture

GMProTM Plasmid Manufacturing

Linearized DNA Manufacture

Proprietary PowerS™-ITRrs Strain

Lentiviral Vector CDMO Services

Cell Line for LVV Manufacturing

Cell Banking

ProLVV Manufacturing

Lentiviral Vector One-stop Solution

LVV Manufacturing

AAV Vector CDMO Services

Cell Line for AAV Manufacturing

ProAAV Manufacturing Service

AAV One-stop Solution

AAV Manufacturing

mRNA CDMO Service


mRNA Manufacture

News & Activities

GenScript-Thermo Fisher Strategic Partnership on Life Sciences and Biopharma

GenScript Biotech's Biologics R&D and Production Center is Formally Put Into Operation

China's Largest Plasmid and Virus Facility from GenScript was Put into Operation

ABL Bio Inc.- GenScript Biotech Corp Bispecific Antibody Strategic Partnership Agreement Ceremony

Chinese CDMO GenScript starts construction of GenScript-Legend Biotech Commercial Manufacturing Center

GenScript and Selecxine Enter Into Strategic Cooperation Agreement

GenScript launches CDMO segment GenScript ProBio at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum

Beroni Group Signs Agreement with GenScript ProBio to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19

GenScript ProBio American Commercial Head, Kenneth Lee gives interview to The Medicine Maker about How we can help customers optimize their developing and manufacturing processes

GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc.

GenScript ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program

GenScript ProBio Wins Bioprocessing Excellence in CDMO Services from IMAPAC

GenScript ProBio Chinese Brand Unveiled, CDMO Capacity Upgraded

Serving a Rising Power

Initium Therapeutics Strategically collaborates with GenScript ProBio

GenScript ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs of Recombinant Coagulation FVIII Based on a Novel Production Technology

SunRock Biopharma and GenScript ProBio Enter into a Collaboration Agreement to Develop Novel Monoclonal Antibody Program

GenScript ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme

GenScript ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII

GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement

GenScript ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea

GenScript ProBio Passed European Union Qualified Person (QP) Audit Successfully

GenScript ProBio and TG ImmunoPharma Enter into Collaboration on Innovative Antibody Drug Project

GenScript ProBio Named a Top 10 Drug Discovery Solution Provider in Asia-Pacific

China’s Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again

GenScript ProBio and AbTis Enter into an Exclusive Worldwide License Agreement for ADC Targeting Claudin 18.2

Successful Groundbreaking Ceremony for GenScript ProBio to Expand Commercial cGMP Plasmid and Viral Vector Manufacturing Facility in Zhenjiang, China

GenScript ProBio initiates a CDMO contract for next-generation CD47 antibody with InnoBation Bio

National Cancer Center Japan and GenScript ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development

GenScript ProBio Signs CDMO Supply Agreement And Forms Strategic Partnership with AffyXell Therapeutics – A Joint Daewong-Avacta Venture

Athenex Partners with Leading Contract Manufacturer GenScript ProBio in the Development of Advanced Cell and Gene Therapies

GenScript ProBio and ProteoNic BV Signed a Strategic Cooperation Based on High Expressing Vector System

GenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies

GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs

GenScript ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program

GenScript ProBio Signs MOU to Form Strategic Partnership with GeneCraft To Development and Production of New AAV gene therapies

GenScript ProBio Enters Strategic Collaboration with Hibiocy Co. Ltd, the affiliate of Rojukiss International Public Company Limited (KISS) – the leading Thai-based Beauty & Health company, for the development and manufacturing of COVITRAP™ and future new

GenScript ProBio Licenses Novel Fc Silencing Technology from mAbsolve

A bispecific antibody molecule jointly developed by Buchang Pharmaceutical and REMD Biotherapeutics,partners of GenScript ProBio, received IND clearance from NMPA for clinical trial

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

GenScript ProBio Congratulates Selecxine’s IND Clearance from MFDS

A Joint Collaboration Between Bio Immunitas and GenScript ProBio Leads to the Development and Fast Track Manufacturing of A Novel Therapeutic Platform

GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate

GenScript ProBio Congratulates Eutilex’s IND Clearance from MFDS

GenScript ProBio and Comprehensive Cell Solutions, a Business Unit of the New York Blood Center Enterprises, Form a Pioneering Partnership to Expedite Cell and Gene Therapy Development and Manufacturing

GenScript ProBio Congratulates IMBiologics on FDA Clearance of IND Application for Innovative Bispecific Antibody Drug Project (IMB-101)

Dx&Vx Signs Strategic Partnership with GenScript ProBio for Novel Drug Development

GenScript ProBio Congratulates ABL Bio’s IND Clearance of ABL103 Program from MFDS

GenScript ProBio Partners with Epi Biotech to Advance Hair Loss Antibody Therapy

The MOU between GenScript ProBio and NuclixBio

GenScript ProBio signs viral vector manufacturing MOU with Curocell for next-generation CAR-T therapy


GenScript ProBio announces the appointment of Dr. Li Chen, as the Chief Executive Officer

GenScript ProBio Extends Congratulations to InnoBation Bio on MFDS Clearance of IBC101 Program


Resource Library



Biologics Webinar Series

Our Heart Goes Out to You, Our Heroes in Combating COVID-19

Global Biologics and CGT Symposium 2023- South Korea

Learning Center

About Us

Management Team

Experience & Expertise



Customer Group

Privacy Policy

Standard Service Agreement

Cookies Policy

Quality Management

Capabilities & Capacity

Regulatory Affairs


Voice of Customer

Site Map

SAP system

GenScript ProBio - 日本語紹介

2024 GenScript Biotech Global Forum